Abstract
In a combined tissue and serum study α-1-antitrypsin (AAT) and α- fetoprotein are demonstrated in parallel within tumor tissue inclusions in both endodermal sinus (yolk sac) tumors and malignant hepatomas, and AAT is demonstrated as a marker in both neoplastic and preneoplastic liver lesions occurring in oral contraceptive users, all in association with normal serum AAT phenotype. The tumor inclusions in the first two instances differ immunocytochemically from AAT liver cell globules found in inherited AAT deficiency, which are unreactive for α-fetoprotein. It is concluded that unlike the molecular basis of storage associated with AAT phenotypic variation, the tumor inclusions reflect a separate, nongenetic mechanism of AAT storage, which may be epigenetic in nature. AAT and α- fetoprotein both are synthesized normally in yolk sac and fetal liver, a parallelism which disappears soon after birth. The reexpression of both proteins in two distinct tumor types arising from endodermal origins (yolk sac and liver), suggests that these markers may represent reemerging fetal gene products, a phenomenon previously proposed only for α-fetoprotein, a prototypic 'oncofetal antigen'.
Cite
CITATION STYLE
Palmer, P. E., & Wolfe, H. J. (1978). Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors. Journal of Histochemistry and Cytochemistry, 26(7), 523–531. https://doi.org/10.1177/26.7.80417
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.